Menu Back toLS31: New System of Clinical Notification for Complexed Clinical Trials
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
18th DIA Japan Annual Meeting 2021
All prices are exclusive of 10% Japanese consumption tax
LS31: New System of Clinical Notification for Complexed Clinical Trials
Toshinori Higashi, PhD
- Regulatory Development Department
- Janssen Pharmaceutical K.K., Japan
- Coordinator, Office of Review Management
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan
- Regulatory Strategy Group2, Japan Regulatory Portfolio Lead
- Pfizer R&D Japan G.K., Japan
Hitomi Okuma, MD, PhD
- Director, Research Planning Office
- National Cancer Center Hospital, Japan